Bill
Bill > S1282
MA S1282
MA S1282Resolve establishing a special commission on psychedelic drug use for clinical trials and therapy
summary
Introduced
03/29/2021
03/29/2021
In Committee
03/29/2021
03/29/2021
Crossed Over
Passed
Dead
12/31/2022
12/31/2022
Introduced Session
192nd General Court
Bill Summary
For legislation to establish a special commission on psychedelic drug use for clinical trials and therapy. Mental Health, Substance Use and Recovery.
AI Summary
This bill establishes a special commission to evaluate and study the costs and benefits of using psychedelic drugs, which are currently being destroyed under existing law, for clinical trials and therapy. The commission will review the benefits of using psychedelic drugs in clinical trials, recommend appropriate regulations, explore the potential for expanding their use from clinical trials to standard therapeutic use, and recommend any changes to existing law regarding psychedelic drugs in Massachusetts. The commission will consist of various state officials and representatives, and it will submit its recommendations, including any proposed legislation, to the legislature by May 1, 2022.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
Accompanied a study order, see S2919 (on 06/09/2022)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://malegislature.gov/Bills/192/S1282 |
| Bill | https://malegislature.gov/Bills/192/S1282.pdf |
Loading...